Sign in
4

Changes in Ownership

Evofem Biosciences, Inc. Filed Acc 0001618835-21-000133

Chief Executive Officer gave up 105,300 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

PELLETIER SAUNDRA L · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-05-20 Shares withheld for taxes : show line 1 in the form −105,300 $0.86 $90,558 800,837 D
Loading xslF345X03/wf-form4_162162870730649.xml…